A carregar...
Cancer immunotherapies targeting the PD-1 signaling pathway
Immunotherapy has recently emerged as the fourth pillar of cancer treatment, joining surgery, radiation, and chemotherapy. While early immunotherapies focused on accelerating T-cell activity, current immune-checkpoint inhibitors take the brakes off the anti-tumor immune responses. Successful clinica...
Na minha lista:
| Publicado no: | J Biomed Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381059/ https://ncbi.nlm.nih.gov/pubmed/28376884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-017-0329-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|